FP7
BTCURE
BeTheCuRE
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 39,371,092
- EU contribution
- EUR 17,362,872
- Participants
- 37 from 16 countries
- Topic
- FP7_IMI-JU-02-2009-06
- Grant agreement
- 115142
Coordinated by Ucb Biopharma (BEBelgium).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Ucb Biopharma | BEBelgium | Coordinator | Not stated | PIC (1.00) |
| Medizinische Universitaet Wien | ATAustria | Participant | EUR 852,328 | PIC (1.00) |
| Universitat Zurich | CHSwitzerland | Participant | EUR 1,008,920 | known name (0.95) |
| Revmatologicky Ustav | CZCzechia | Participant | EUR 279,240 | known name (0.95) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 601,846 | PIC (1.00) |
| Deutsches Rheuma Forschungszentrumberlin | DEGermany | Participant | EUR 377,625 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Universitatsklinikum Erlangen | DEGermany | Participant | EUR 864,761 | known name (0.97) |
| Novo Nordisk A/S | DKDenmark | Participant | Not stated | PIC (1.00) |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | ESSpain | Participant | EUR 277,960 | PIC (1.00) |
| Centre Hospitalier Universitaire Montpellier | FRFrance | Participant | EUR 367,518 | PIC (1.00) |
| Firalis | FRFrance | Participant | EUR 89,577 | PIC (1.00) |
| Firalis Molecular Precision SA | FRFrance | Participant | EUR 80,113 | PIC (1.00) |
| Institut National de la Sante et de la Recherche Medicale | FRFrance | Participant | EUR 281,363 | known name (0.95) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 544,792 | known name (0.95) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 549,246 | PIC (1.00) |
| The University of Manchester | GBUnited Kingdom | Participant | EUR 592,841 | known name (0.95) |
| University of Glasgow | GBUnited Kingdom | Participant | EUR 743,191 | known name (0.95) |
| University of Leeds | GBUnited Kingdom | Participant | EUR 600,769 | known name (0.95) |
| Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis | GRGreece | Participant | EUR 99,099 | PIC (1.00) |
| Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk | GRGreece | Participant | EUR 852,394 | PIC (1.00) |
| Idryma Iatroviologikon Ereunon Akademias Athinon | GRGreece | Participant | EUR 330,746 | PIC (1.00) |
| University College Dublin, National University of Ireland, Dublin | IEIreland | Participant | EUR 366,269 | VAT number (0.97) |
| Fondazione Humanitas Per la Ricerca | ITItaly | Participant | EUR 609,993 | PIC (1.00) |
| Academisch Ziekenhuis Leiden | NLNetherlands | Participant | EUR 1,810,684 | PIC (1.00) |
| Arthrogen BV | NLNetherlands | Participant | Not stated | PIC (1.00) |
| Janssen Biologics BV | NLNetherlands | Participant | Not stated | PIC (1.00) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 415,024 | known name (0.95) |
| Diakonhjemmet Sykehus As | NONorway | Participant | EUR 92,226 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Karolinska Institutet | SESweden | Participant | EUR 3,279,727 | known name (0.95) |
| Phadia AB | SESweden | Participant | Not stated | PIC (1.00) |
| Redoxis AB | SESweden | Participant | EUR 1,035 | PIC (1.00) |
| Uppsala Universitet | SESweden | Participant | EUR 270,690 | known name (0.95) |
| Bristol-Myers Squibb Company Corp | USUnited States | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 37 participants from 15 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.